MetLife Investment Management’s AST SpaceMobile ASTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.21M Buy
13,611
+1,064
+8% +$92.8K 0.01% 1426
2026
Q1
$1.04M Sell
12,547
-860
-6% -$81.2K 0.01% 1376
2025
Q4
$974K Buy
13,407
+1,778
+15% +$127K ﹤0.01% 1446
2025
Q3
$571K Buy
11,629
+1,509
+15% +$72.7K ﹤0.01% 1741
2025
Q2
$473K Sell
10,120
-69,219
-87% -$2M ﹤0.01% 1702
2025
Q1
$1.8M Sell
79,339
-2,221
-3% -$56.8K 0.01% 1087
2024
Q4
$1.72M Buy
81,560
+5,258
+7% +$128K 0.01% 1120
2024
Q3
$2M Buy
76,302
+8,441
+12% +$190K 0.01% 1019
2024
Q2
$788K Buy
67,861
+6,332
+10% +$33.1K ﹤0.01% 1475
2024
Q1
$178K Buy
61,529
+17,141
+39% +$57.5K ﹤0.01% 2258
2023
Q4
$268K Hold
44,388
– – ﹤0.01% 2069
2023
Q3
$169K Buy
44,388
+11,451
+35% +$46.2K ﹤0.01% 2301
2023
Q2
$155K Buy
+32,937
New +$171K ﹤0.01% 2418

Other funds holding ASTS

MetLife Investment Management's ASTS Position: Q2 2026 in Review

MetLife Investment Management increased its AST SpaceMobile (ASTS) stake by 8.5% in Q2 2026, buying an estimated $92.8K and bringing the position to 13,611 shares worth $1.21M. The position accounts for 0.01% of the portfolio, ranked #1426.

MetLife Investment Management first reported a position in ASTS in Q2 2023 and has held it in 13 quarters since. The position peaked at $2M in Q3 2024. 756 funds tracked by Wall St. Rank hold ASTS as of Q2 2026.

  • MetLife Investment Management held 13,611 shares of AST SpaceMobile worth $1.21M as of Q2 2026.
  • MetLife Investment Management bought 1,064 AST SpaceMobile shares in Q2 2026, an estimated $92.8K.
  • AST SpaceMobile made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1426 holding.
  • MetLife Investment Management first reported a position in AST SpaceMobile in Q2 2023 and has held it in 13 quarters since.
  • MetLife Investment Management's AST SpaceMobile position peaked at $2M in Q3 2024.
  • 756 funds tracked by Wall St. Rank held AST SpaceMobile as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.